What to do and how to treat lymphoma after recurrence

The treatment of lymphoma has achieved certain results and the disease has been controlled, but if it recurs, it will make the patient disappointed, worried and anxious. Therefore, it is necessary to pay attention to the problem of recurrence and do a good job of prevention. So what should I do if lymphoma recurs? How should I treat it again?

Active treatment should be adopted after relapse. Regardless of the type of lymphoma, after changing the chemotherapy regimen and re-treatment, most patients will relapse again. If they rely solely on conventional chemotherapy at conventional doses, it is difficult for patients with aggressive non-Hodgkin's lymphoma and Hodgkin's lymphoma to get a chance of cure. Therefore, for this type of lymphoma, if it is a young patient, it is recommended to consider high-dose chemotherapy combined with autologous stem cell transplantation as soon as possible when the second treatment effect is better. Some patients still have hope of cure. When necessary, allogeneic stem cell transplantation is even required. Although repeated treatments are still effective for patients with indolent lymphoma, the effective duration of most types will become shorter and shorter, the frequency of relapses will become higher and higher, and the efficacy will become worse and worse. Therefore, young patients should also consider active treatments such as stem cell transplantation.

How to treat lymphoma recurrence after surgery? Bone marrow transplantation: Bone marrow transplantation has two uses in the treatment of recurrence of moderate and high-grade malignant lymphoma. One is as a basis for chemotherapy with a higher dose, and the other is both for chemotherapy and to replace the patient's bone marrow with the donor's bone marrow. Chinese medicine treatment: Recurring patients are generally in the middle and late stages. A large number of clinical practices have shown that high-dose radiotherapy and chemotherapy for patients in the middle and late stages, or chemotherapy again for patients who have developed drug resistance, can only make the weak life more critical and accelerate the patient's death.